Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024
Impact
The bill specifically mandates the Secretary to develop evidence-based strategies within healthcare settings for increased early detection of uterine fibroids, thereby intending to mitigate any health complications that arise from delayed identification. Additionally, it allows the Secretary to provide grants to states to implement programs aimed at improving public awareness and intervention strategies for uterine fibroids.
Summary
House Bill 8247, titled the ‘Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2024’, aims to authorize the Secretary of Health and Human Services to increase research and grant funding focused on the early detection and intervention of uterine fibroids. This bill seeks to enhance the understanding of this medical condition which affects many women and to promote measures that can lead to better health outcomes through timely interventions.
Contention
While the bill is framed as a progressive step towards healthcare modernization and improvement, there might be points of contention regarding funding allocations and the effectiveness of proposed intervention programs. Opponents might raise concerns about whether such programs will reach the intended populations or effectively address disparities in healthcare access and outcomes among different demographic groups.
Reforms the organizational structure for the Department of Transportation and Development including its duties, powers, and responsibilities of officers and employees (EN INCREASE SD EX See Note)